Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
STAT3 is Overactivated in Gastric Cancer Stem-Like Cells.
Hajimoradi M, Mohammad Hassan Z, Ebrahimi M, Soleimani M, Bakhshi M, Firouzi J, Samani FS. Hajimoradi M, et al. Cell J. 2016 Winter;17(4):617-28. doi: 10.22074/cellj.2016.3834. Epub 2016 Jan 17. Cell J. 2016. PMID: 26862521 Free PMC article.
Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models.
Banihashemi SR, Es-Haghi A, Fallah Mehrabadi MH, Nofeli M, Mokarram AR, Ranjbar A, Salman M, Hajimoradi M, Razaz SH, Taghdiri M, Bagheri M, Dadar M, Hassan ZM, Eslampanah M, Salehi Najafabadi Z, Lotfi M, Khorasani A, Rahmani F. Banihashemi SR, et al. Among authors: hajimoradi m. Front Immunol. 2022 May 26;13:836745. doi: 10.3389/fimmu.2022.836745. eCollection 2022. Front Immunol. 2022. PMID: 35693788 Free PMC article.
Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial.
Dodaran MS, Banihashemi SR, Es-Haghi A, Mehrabadi MHF, Nofeli M, Mokarram AR, Mokhberalsafa L, Sadeghi F, Ranjbar A, Ansarifar A, Mohazzab A, Setarehdan SA, Bagheri Amiri F, Mohseni V, Hajimoradi M, Ghahremanzadeh N, Razzaz SH, Masoomi S, Taghdiri M, Bagheri M, Lofti M, Khorasani A, Ghader M, Safari S, Shahsavn M, Kalantari S. Dodaran MS, et al. Among authors: hajimoradi m. Vaccines (Basel). 2023 Feb 16;11(2):455. doi: 10.3390/vaccines11020455. Vaccines (Basel). 2023. PMID: 36851334 Free PMC article.
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial.
Erfanpoor S, Banihashemi SR, Mokhbaeralsafa L, Kalantari S, Es-Haghi A, Nofeli M, Rezaei Mokarram A, Sadeghi F, Hajimoradi M, Razaz SH, Taghdiri M, Lotfi M, Khorasani A, Ansarifar A, Masoumi S, Mohazzab A, Filsoof S, Mohseni V, Shahsavan M, Gharavi N, Setarehdan SA, Rabiee MH, Fallah Mehrabadi MH, Solaymani-Dodaran M. Erfanpoor S, et al. Among authors: hajimoradi m. BMC Med. 2024 Feb 20;22(1):78. doi: 10.1186/s12916-024-03295-1. BMC Med. 2024. PMID: 38378570 Free PMC article. Clinical Trial.
The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.
Serati A, Keshmiri MS, Shafaghi S, Mohammad MM, Kashani BS, Naghashzadeh F, Mohamadifar A, Shafaghi M, Noorali S, Hajimoradi M, Astani B, Aghdasi S, Riahi M, Alavi S, Malek R, Movahed MR. Serati A, et al. Among authors: hajimoradi m. Crit Pathw Cardiol. 2023 Jun 1;22(2):60-64. doi: 10.1097/HPC.0000000000000317. Epub 2023 Mar 23. Crit Pathw Cardiol. 2023. PMID: 37220659
Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID-19 in the Omicron variant era: A national cohort study in Iran.
Jamaati H, Karimi S, Ghorbani F, Panahi Y, Hosseini-Baharanchi FS, Hajimoradi M, Malek R, Noorali S, Mokhtari M, Khoundabi B, Sadr M, Mohamadnia A, Zahraei SM, Hashemian SM, Dastan F, Mortaz E, Tayeri K, Behtaj F, Vaezi H, Forouzanfar MM, Shafaghi S. Jamaati H, et al. Among authors: hajimoradi m. J Med Virol. 2023 Mar;95(3):e28607. doi: 10.1002/jmv.28607. J Med Virol. 2023. PMID: 36815507
Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study.
Hajimoradi M, Sharif Kashani B, Dastan F, Aghdasi S, Abedini A, Naghashzadeh F, Mohamadifar A, Keshmiri MS, Noorali S, Lookzadeh S, Alizadeh N, Siri MA, Tavasolpanahi M, Abdolmohammadi Y, Shafaghi M, Rouhani ZS, Shafaghi S. Hajimoradi M, et al. Front Pharmacol. 2023 Jan 17;13:1107198. doi: 10.3389/fphar.2022.1107198. eCollection 2022. Front Pharmacol. 2023. PMID: 36733376 Free PMC article.
17 results